首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Detection of Circulating Galactomannan in Serum Samples for Diagnosis of Penicillium marneffei Infection and Cryptococcosis among Patients Infected with Human Immunodeficiency Virus
【2h】

Detection of Circulating Galactomannan in Serum Samples for Diagnosis of Penicillium marneffei Infection and Cryptococcosis among Patients Infected with Human Immunodeficiency Virus

机译:血清样本中循环半乳甘露聚糖的检测以检测感染人类免疫缺陷病毒的患者的马尔尼菲青霉菌感染和隐球菌病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Galactomannan (GM) is a heteropolysaccharide in the cell walls of most Aspergillus and Penicillium species. Cross-reactivity of Cryptococcus neoformans galactoxylomannan in an Aspergillus GM test has also been reported. In this study, we used a Platelia Aspergillus enzyme immunoassay kit (Bio-Rad) to test serum samples obtained from 48 human immunodeficiency virus (HIV)-infected patients (15 with penicilliosis [7 with fungemia alone, 4 with cavitary lung lesions alone, 3 with both fungemia and cavitary lung lesions, and 1 with disseminated disease], 22 with cryptococcosis [11 with fungemia alone, 5 with cavitary lung lesions, 3 with both, and 3 with meningitis alone], and 11 without any invasive fungal infection [control]) for GM levels. None of the patients had aspergillosis or concurrent use of piperacillin-tazobactam or amoxicillin-clavulanate. The median time between diagnosis of fungal infection and collection of serum samples was 0 days for penicilliosis and 1.5 days for cryptococcosis. Of patients with penicilliosis, cryptococcosis, and controls, 73.3%, 13.6%, and 9%, respectively, had GM optical density (OD) indices of >0.5 (P = 0.0001). GM OD indices were higher for penicilliosis (median OD index, 4.419; range, 0.158 to >20) than for cryptococcosis (median, 0.247; range, 0.112 to 3.849) cases (P < 0.001). Patients with fungemic penicilliosis had higher OD indices (median, 10.628; range, 0.401 to >20) than patients with nonfungemic penicilliosis (median, 0.378; range, 0.158 to 4.419) and patients with cryptococcemia (median, 0.231; range, 0.112 to 1.168) (P < 0.001). Of the 15 patients with cavitary lung lesions, those with penicilliosis had higher antigen levels (median OD index, 1.641; range, 0.247 to >20) than those with cryptococcosis (median, 0.227; range, 0.112 to 3.849) (P = 0.011). This study showed that the GM OD index was significantly elevated for HIV patients with penicilliosis. The use of the GM antigen assay may facilitate earlier diagnosis of Penicillium marneffei infection for HIV-infected patients in areas of endemicity.
机译:半乳甘露聚糖(GM)是大多数曲霉和青霉菌种细胞壁中的杂多糖。还已经报道了曲霉GM试验中新隐球菌半乳甘露聚糖的交叉反应性。在这项研究中,我们使用了Platelia Aspergillus酶免疫测定试剂盒(Bio-Rad),测试了从48例感染了人类免疫缺陷病毒(HIV)的患者(15例青霉病[7例为真菌病,4例为肺空洞病变, 3例同时伴有真菌血症和空洞性肺病,1例伴有弥散性疾病],22例隐球菌病[仅11例伴有真菌血症,5例伴有空洞性肺病,3例同时伴有3例,3例伴有脑膜炎],11例未伴有任何侵袭性真菌感染[对照])。所有患者均无曲霉病或哌拉西林-他唑巴坦或阿莫西林-克拉维酸盐同时使用。诊断真菌感染与收集血清样品之间的中位时间,青霉菌病为0天,隐球菌病为1.5​​天。在青霉菌病,隐球菌病和对照患者中,GM光密度(OD)指数分别> 0.5(P = 0.0001),分别为73.3%,13.6%和9%。青霉菌病的GM OD指数(中位数OD指数为4.419;范围为0.158至> 20)高于隐球菌病(中位数为0.247;范围为0.112至3.849)(P <0.001)。真菌性青霉病患者的OD指数(中位数为10.628;范围为0.401至> 20)高于非真菌性青霉菌病患者(中值为0.378;范围为0.158至4.419)和隐球菌血症患者(中位数为0.231;范围为0.112至1.168) )(P <0.001)。在15例肺空洞病变患者中,青霉病患者的抗原水平(中位数OD指数为1.641;范围为0.247至> 20)高于隐球菌病(中位数为0.227;范围为0.112至3.849)(P = 0.011) 。这项研究表明,HIV青霉病患者的GM OD指数显着升高。 GM抗原测定法的使用可以促进对地方病地区HIV感染患者的马尔尼菲青霉感染的早期诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号